CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-10 | Wang Xiaodong Director | Sale | −1,100 | $299.40 | $329K | 2,294 |
| 2021-05-10 | Wang Xiaodong Director | Sale | −1,594 | $300.20 | $479K | 700 |
| 2021-05-10 | Wang Xiaodong Director | Sale | −311 | $302.21 | $94K | 389 |
| 2021-05-10 | Wang Xiaodong Director | Sale | −389 | $303.10 | $118K | 0 |
| 2021-05-10 | Wang Xiaodong Director | Option exercise · Share Option (Right to Buy) | −88,231 | 4 | ||
| 2021-05-03 | Wu Xiaobin President, COO & GM China | Sale | −6,715 | $343.00 | $2.3M | 0 |
| 2021-04-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −100 | $350.25 | $35K | 1,400 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −200 | $352.67 | $71K | 1,200 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −300 | $353.94 | $106K | 900 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −400 | $355.12 | $142K | 500 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −300 | $356.25 | $107K | 200 |
| 2021-04-29 | Huang Jane CMO, Hematology | Sale | −200 | $358.62 | $72K | 0 |
| 2021-04-29 | Huang Jane CMO, Hematology | Option exercise · Share Option (Right to Buy) | −19,500 | 246,575 | ||
| 2021-03-29 | Huang Jane CMO, Hematology | Option exercise | +1,500 | $29.49 | $44K | 1,500 |
| 2021-03-29 | Huang Jane CMO, Hematology | Sale | −300 | $321.94 | $97K | 1,200 |
| 2021-03-29 | Huang Jane CMO, Hematology | Sale | −395 | $323.31 | $128K | 805 |
| 2021-03-29 | Huang Jane CMO, Hematology | Sale | −378 | $324.14 | $123K | 427 |
| 2021-03-29 | Huang Jane CMO, Hematology | Sale | −200 | $325.56 | $65K | 227 |
| 2021-03-29 | Huang Jane CMO, Hematology | Sale | −227 | $326.29 | $74K | 0 |
Page 72 of 99 · 1,972 trades